Isofol Medical AB (publ)

Isofol is a publicly listed biotechnology company focused on advancing cancer care. The organization is dedicated to developing its drug candidate, arfolitixorin, a novel folate-based therapy. Arfolitixorin is specifically designed to enhance the efficacy of standard first-line treatments for severe...